LOCAL AND SYSTEMIC ESTRADIOL-17-BETA - EFFECTS ON UTERINE AND SYSTEMIC VASODILATION

LOCAL AND SYSTEMIC ESTRADIOL-17-BETA - EFFECTS ON UTERINE AND SYSTEMIC VASODILATION
复制标题

DOI:
10.1152/ajpendo.1989.256.4.e536
复制
发表时间:
1989-04-01
影响因子:
--
通讯作者:
ROSENFELD, CR
ROSENFELD, CR
中科院分区:
其他
文献类型:
--
作者:
MAGNESS, RR;ROSENFELD, CR

文献摘要

被引文献

相似文献

Systemic estradiol-17.beta. (E2.beta.) administration increases uterine blood flow (UBF), cardiac output (CO), heart rate (HR), and plasma renin activity (PRA). We sought to determine if the E2.beta.-induced systemic responses were dependent on the observed uterine responses. Nonpregnant, ovariectomized ewes (n = 5) received 3 .mu.g E2.beta. into both uterine arteries followed 120 min later by systemic E2.beta., 1 .mu.g/kg. At 120 min after local E2.beta., UBF increased from 26 .+-. 5 to 161 .+-. 21 ml/min (P < 0.05); uterine vascular resistance (UVR) decreased 83 .+-. 2.5% (P < 0.05); and systemic parameters were unchanged. At 120 min after systemic E2.beta., UBF remained elevated and CO had increased gradually from 4.4 .+-. 0.2 to 5.5 .+-. 0.32 l/min (26 .+-. 3.4%; P < 0.05), reflecting a 37 .+-. 3.9% (P < 0.05) increase in HR; mean arterial pressure (MAP) remained unchanged. The increased CO was associated with a 20 .+-. 3.1% (P < 0.05) fall in systemic vascular resistance (SVR), with %.DELTA.SVR < %.DELTA.UVR (P < 0.05). Base-line PRA and angiotensin II, 1.31 .+-. 0.2 ng .cntdot. ml-1 .cntdot. h-1 and 10.3 .+-. 2.1 pg/ml, respectively, were unchanged by local E2.beta.; systemic E2.beta. caused increases to 3.56 .+-. 0.51 ng .cntdot. ml-1 .cntdot. h-1 (P < 0.05) and 34.1 .+-. 11.3 pg/ml (P < 0.05), respectively. E2.beta.-induced uterine hyperemia occurs independent of its systemic effects and is not responsible for systemic cardiovascular alterations, and the relative uterine vascular responses exceed systemic responses. Systemic responses, e.g., heart rate-mediated increases in CO, are associated with maintenance of MAP, decreases in SVR, and increases in PRA and angiotensin II that are not of uterine origin.